SEC Form 4 · accession 0000899243-15-004744
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis E Odonnell Jr.
Officer — Executive Chairman · Director
Period of report
Sep 10, 2015
Accepted (ET)
Sep 14, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value per shareF1,F2 | Sep 10, 2015 | P$0 | 20,000,000 | — | A | 20,000,000 | I | By Hopkins Capital Group II, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On the September 10, 2015, Hedgepath, LLC transferred 20,000,000 shares of common stock to Hopkins Capital Group II, LLC ("HCGII") in satisfaction of $1,577,797.54 in then outstanding debt.
- F2The shares are owned by HCGII. The Reporting Person is the co-manager of HCGII. Filing of this statement shall not be deemed an admission by the Reporting Person that he beneficially owns the securities held by HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.